fusidic acid has been researched along with Impetigo Contagiosa in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.44) | 18.7374 |
1990's | 3 (6.67) | 18.2507 |
2000's | 26 (57.78) | 29.6817 |
2010's | 10 (22.22) | 24.3611 |
2020's | 4 (8.89) | 2.80 |
Authors | Studies |
---|---|
Goebeler, M; Hamm, H; Mohme, S | 1 |
de Boer, A; Denie-Verhaegh, E; Dimmendaal, M; Hooiveld, M; Koene, FMHPA; Kuijper, EJ; Notermans, DW; Petrignani, M; Postma, B; Ruijs, WLM; Schoffelen, AF; Schouls, LM; Silvis, W; Vendrik, KEW; Witteveen, S | 1 |
Bustos Sierra, N; Deplano, A; Hallin, M; Martiny, D; Michel, C; Prevost, B; Yin, N | 1 |
Andriessen, A; Benjamin, LT; Claro, C; Eichenfield, LF; Esposito, SM; Keller, L; Kircik, L; Kwong, PC; McCuaig, C; Schachner, LA | 1 |
Freemantle, N; Hayward, AC; Johnson, AM; Petersen, I; Rosenthal, J; Shallcross, LJ | 1 |
Lanier, J; Qui, MK; Shim, J | 1 |
Langeland, N; Rortveit, G; Rørtveit, S; Skutlaberg, DH | 2 |
Best, E; Lennon, D; Leversha, A; Vogel, A | 1 |
Bes, M; Croze, M; Etienne, J; Laurent, F; Lina, G; Meugnier, H; Tristan, A; Vandenesch, F | 1 |
Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J | 1 |
Andresen, LK | 1 |
Brown, M; Kong, F; Liu, Y; Ma, L; Yang, Y; Zhang, X | 1 |
Lomholt, HB | 1 |
Alsterholm, M; Bergbrant, IM; Faergemann, J; Flytström, I | 1 |
De Nicolao, G; Della Pasqua, O; Russu, A; van Zwet, E | 1 |
Berger, M; Butler, CC; Koning, S; Morris, AD; van der Sande, R; van der Wouden, JC; van Suijlekom-Smit, LW; Verhagen, AP | 1 |
Bruggeman, CA; den Heyer, M; Hopstaken, RM; Rijnders, MI; Stobberingh, EE; Wolffs, PF | 1 |
Jenkins, A; Kristiansen, BE; Tveten, Y | 1 |
Eden, T; Haeggman, S; Kahlmeter, G; Olsson-Liljequist, B; Osterlund, A | 1 |
Akiyama, H; Fujimoto, W; Hamada, T; Huh, WK; Iwatsuki, K; Oono, T; Yamasaki, O | 1 |
Koning, S; Nouwen, J; Op 't Veld, M; Snijders, S; van Belkum, A; van der Wouden, JC; van Leeuwen, W; van Suijlekom-Smit, LW; Verbrugh, H; Verduin, C | 1 |
George, A; Rubin, G | 1 |
Tveten, Y | 1 |
Del Mar, C; Gunn, H | 1 |
Rørtveit, G; Rørtveit, S | 1 |
Chopra, I; Henriksen, AS; Larsen, AR; O'Neill, AJ | 1 |
Johnston, GA; Sladden, MJ | 1 |
Mazereeuw-Hautier, J | 1 |
Chopra, I; Henriksen, AS; Larsen, AR; O'Neill, AJ; Skov, R | 1 |
Rortveit, G; Rørtveit, S | 1 |
Chosidow, O; Oranje, AP; Sacchidanand, S; Scangarella, N; Shawar, R; Singh, K; Todd, G; Twynholm, M | 1 |
Cassels-Brown, G | 1 |
Anehus, S; Christensen, OB | 1 |
Clyti, E; Couppié, P; Gravet, A; Monteil, H; Moreau, B; Pradinaud, R; Prévost, G; Sainte-Marie, D | 1 |
Bryant, J; Gisby, J | 1 |
Bernsen, RM; Koning, S; Nouwen, JL; Oranje, AP; Thomas, S; van der Wouden, JC; van Suijlekom-Smit, LW; Verduin, CM | 1 |
Brown, EM; Wise, R | 1 |
Brown, DF; Brown, N; Burrows, N; Sule, O | 1 |
Boswell, TC; Finch, RG; Perkins, W; Weston, VC | 1 |
Collyns, T; Denton, M; Stoddart, B | 1 |
Young, N; Zadik, P | 1 |
Cheesbrough, JS; Owen, SE | 1 |
Johnston, C | 1 |
Morley, PA; Munot, LD | 1 |
6 review(s) available for fusidic acid and Impetigo Contagiosa
Article | Year |
---|---|
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Bridged Bicyclo Compounds, Heterocyclic; Critical Pathways; Delphi Technique; Diterpenes; Drug Resistance, Bacterial; Evidence-Based Medicine; Fusidic Acid; Humans; Impetigo; Microbial Sensitivity Tests; Mupirocin; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Streptococcus pyogenes; Systematic Reviews as Topic | 2021 |
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
Interventions for impetigo.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Erythromycin; Fusidic Acid; Humans; Impetigo; Mupirocin; Penicillins; Randomized Controlled Trials as Topic | 2012 |
A systematic review and meta-analysis of treatments for impetigo.
Topics: Administration, Topical; Adolescent; Algorithms; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Family Practice; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Mupirocin; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Current options for the treatment of impetigo in children.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Fusidic Acid; Humans; Impetigo; Infant; Mupirocin; Randomized Controlled Trials as Topic; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus; Streptococcus pyogenes | 2005 |
[Impetigo].
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors | 2006 |
6 trial(s) available for fusidic acid and Impetigo Contagiosa
Article | Year |
---|---|
Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Exfoliatins; Exotoxins; Fusidic Acid; Genetic Markers; Humans; Impetigo; Leukocidins; Nose; Plasmids; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Virulence | 2003 |
Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Child; Child, Preschool; Diterpenes; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Male; Middle Aged; Ointments; Single-Blind Method; Skin; Staphylococcus aureus; Streptococcus pyogenes; Treatment Outcome | 2007 |
A comparative study of Fucidin Ointment and Cicatrin Cream in the treatment of impetigo.
Topics: Adolescent; Adult; Aged; Bacitracin; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Middle Aged; Neomycin; Ointments; Random Allocation | 1981 |
Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Blister; Child; Child, Preschool; Double-Blind Method; Exudates and Transudates; Female; Follow-Up Studies; Fusidic Acid; Gels; Humans; Hydrogen Peroxide; Impetigo; Male; Middle Aged; Ointments; Placebos | 1994 |
Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Family Practice; Female; Follow-Up Studies; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Logistic Models; Male; Ointments; Povidone-Iodine; Staphylococcus; Treatment Outcome | 2002 |
A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Fatty Acids; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Middle Aged; Mupirocin; Ointments; Skin Diseases, Infectious | 1988 |
33 other study(ies) available for fusidic acid and Impetigo Contagiosa
Article | Year |
---|---|
A blistering child: a toddler with large bullae.
Topics: Anti-Bacterial Agents; Blister; Cefaclor; Child, Preschool; Fusidic Acid; Humans; Imines; Impetigo; Male; Pyridines; Skin Cream | 2021 |
An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant
Topics: Anti-Bacterial Agents; Child; Disease Outbreaks; Fusidic Acid; Humans; Impetigo; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Netherlands; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
Topics: Anti-Bacterial Agents; Belgium; Clone Cells; Drug Resistance, Bacterial; Fusidic Acid; Humans; Impetigo; Methicillin-Resistant Staphylococcus aureus; Multilocus Sequence Typing; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Epidemics; Epidemiological Monitoring; Fusidic Acid; Humans; Impetigo; Infant; Primary Health Care; United Kingdom | 2013 |
The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Drug Resistance, Bacterial; Epidemics; Female; Fusidic Acid; Humans; Impetigo; Incidence; Male; Middle Aged; Molecular Typing; Norway; Staphylococcus aureus | 2014 |
Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Methicillin-Resistant Staphylococcus aureus; New Zealand; Staphylococcal Infections | 2016 |
Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Drug Resistance, Bacterial; France; Fusidic Acid; Humans; Impetigo; Staphylococcal Skin Infections; Staphylococcus aureus | 2009 |
[Managing children skin and soft tissue infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes | 2008 |
[Deficient documentation in the guidelines for antibiotics use].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Practice Guidelines as Topic; Primary Health Care | 2009 |
Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; China; DNA, Bacterial; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Skin Infections; Virulence Factors | 2009 |
Fusidic acid resistant Staphylococcus aureus and skin disease.
Topics: Administration, Topical; Anti-Bacterial Agents; Blister; Dermatitis, Atopic; Drug Resistance, Bacterial; Fusidic Acid; Humans; Impetigo; Patient Selection; Staphylococcus aureus | 2010 |
Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blister; Child; Child, Preschool; Dermatitis, Atopic; Drug Resistance, Bacterial; Female; Fusidic Acid; Humans; Impetigo; Infant; Infant, Newborn; Male; Middle Aged; Patient Selection; Prospective Studies; Retrospective Studies; Staphylococcus aureus; Sweden; Young Adult | 2010 |
Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fusidic Acid; Humans; Impetigo; Incidence; Molecular Typing; Norway; Staphylococcal Infections; Staphylococcus aureus | 2011 |
Modelling of the outcome of non-inferiority trials by integration of historical data.
Topics: Anti-Bacterial Agents; Bayes Theorem; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Databases, Factual; Double-Blind Method; Fusidic Acid; Humans; Impetigo; Placebos; Research Design; Sample Size; Software; Treatment Outcome | 2011 |
Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Cluster Analysis; Drug Resistance, Bacterial; Female; Fusidic Acid; General Practice; Genes, Bacterial; Genotype; Humans; Impetigo; Infant; Male; Middle Aged; Molecular Typing; Netherlands; Prevalence; Staphylococcal Protein A; Staphylococcus aureus; Young Adult | 2012 |
A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway.
Topics: Clone Cells; Drug Resistance, Bacterial; Fusidic Acid; Humans; Impetigo; Norway; Staphylococcus aureus | 2002 |
Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.
Topics: Administration, Topical; Age Distribution; Child; Child, Preschool; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Ointments; Prevalence; Probability; Retrospective Studies; Sensitivity and Specificity; Sex Distribution; Staphylococcus aureus; Sweden | 2002 |
Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus foliaceus.
Topics: Acetic Acid; Adolescent; Adult; Aged; Biofilms; Child; Child, Preschool; Colony Count, Microbial; Dermatitis, Atopic; Female; Fibrin; Fusidic Acid; Glycocalyx; Humans; Hydrochloric Acid; Impetigo; Male; Microscopy, Confocal; Middle Aged; Pemphigus; Staphylococcus aureus | 2003 |
[Impetigo bullosa].
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Impetigo; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Systemic or topical treatment for impetigo?
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Child, Preschool; Evidence-Based Medicine; Fusidic Acid; Humans; Impetigo; Male; Penicillins; Treatment Outcome | 2003 |
[An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Impetigo; Middle Aged; Norway; Staphylococcal Infections; Staphylococcus aureus | 2003 |
A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Europe; Fusidic Acid; Genes, Bacterial; Humans; Impetigo; Microbial Sensitivity Tests; Multigene Family; Mutation; Peptide Elongation Factor G; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.
Topics: Bacterial Proteins; Disease Outbreaks; Drug Resistance, Bacterial; Europe; Fusidic Acid; Gene Expression Regulation, Bacterial; Genotype; Humans; Impetigo; Staphylococcus aureus; Virulence Factors | 2007 |
Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Disease Outbreaks; Female; Fusidic Acid; Humans; Impetigo; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Norway | 2007 |
[Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study].
Topics: Adolescent; Anti-Bacterial Agents; Child; Chlortetracycline; Diagnosis, Differential; Female; Fusidic Acid; Humans; Impetigo; Josamycin; Male; Oxacillin; Penicillins; Prospective Studies; Roxithromycin | 1998 |
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacitracin; Cephalexin; Chemistry, Pharmaceutical; Cricetinae; Erythromycin; Female; Floxacillin; Fusidic Acid; Impetigo; Male; Mice; Mupirocin; Neomycin; Penicillins; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Wound Infection | 2000 |
Fusidic acid cream for impetigo. Fusidic acid should be used with restraint.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Staphylococcus aureus | 2002 |
Fusidic acid cream for impetigo. Judicious use is advisable.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Staphylococcus aureus | 2002 |
Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Staphylococcus aureus | 2002 |
Fusidic acid cream for impetigo. Problem may be clinically important.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Staphylococcus aureus | 2002 |
Fusidic acid cream for impetigo. Resistance trends must be monitored.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Staphylococcus aureus | 2002 |
Fusidic acid cream for impetigo. Findings cannot be extrapolated.
Topics: Anti-Bacterial Agents; Child; Drug Resistance, Microbial; Fusidic Acid; Humans; Impetigo; Staphylococcus aureus | 2002 |
Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
Topics: Administration, Cutaneous; Anti-Bacterial Agents; Fatty Acids; Fusidic Acid; Humans; Impetigo; Mupirocin; Ointments | 1991 |